APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cas9 Nuclease

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cas9 Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchCas9 Nuclease Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Cas9 Nuclease Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cas9 Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cas9 Nuclease Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Cas9 Nuclease Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cas9 Nuclease market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cas9 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cas9 Nuclease include SBS Genetech, Novoprotein, Agilent, Thermo Fisher Scientific, Stemcell Technologies, Sigma-Aldrich, OriGene Technologies, Nippon Gene and New England Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cas9 Nuclease market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cas9 Nuclease and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cas9 Nuclease sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cas9 Nuclease market size, projected growth trends, production technologies, key applications, and end-use industries.

Cas9 Nuclease Segment by Company

SBS Genetech

Novoprotein

Agilent

Thermo Fisher Scientific

Stemcell Technologies

Sigma-Aldrich

OriGene Technologies

Nippon Gene

New England Biolabs

Kactus

Horizo​​n Discovery

GenScript

Danaher

BPS Bioscience

Applied Biological Materials

Abnova

Cas9 Nuclease Segment by Type

Cas9 mRNA

Cas9 Protein

Cas9 Lentivirus

Cas9 Plasmid

Cas9 Nuclease Segment by Application

Bioagriculture

Gene Therapy

Gene Editing Cell Line Construction

Animal Models

Other

Cas9 Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas9 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cas9 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas9 Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cas9 Nuclease market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cas9 Nuclease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cas9 Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cas9 Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cas9 Nuclease Industry Trends Table 2. Cas9 Nuclease Industry Drivers Table 3. Cas9 Nuclease Industry Opportunities and Challenges Table 4. Cas9 Nuclease Industry Restraints Table 5. Global Cas9 Nuclease Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cas9 Nuclease Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cas9 Nuclease Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cas9 Nuclease Sales Market Share by Manufacturers Table 9. Global Cas9 Nuclease Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cas9 Nuclease Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cas9 Nuclease Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cas9 Nuclease Manufacturers, Product Type & Application Table 13. Global Cas9 Nuclease Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cas9 Nuclease by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cas9 mRNA Table 17. Major Manufacturers of Cas9 Protein Table 18. Major Manufacturers of Cas9 Lentivirus Table 19. Major Manufacturers of Cas9 Plasmid Table 20. Global Cas9 Nuclease Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Cas9 Nuclease Sales by Type (2021-2026) & (K Units) Table 22. Global Cas9 Nuclease Sales by Type (2027-2032) & (K Units) Table 23. Global Cas9 Nuclease Sales Market Share by Type (2021-2026) Table 24. Global Cas9 Nuclease Sales Market Share by Type (2027-2032) Table 25. Global Cas9 Nuclease Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Cas9 Nuclease Revenue by Type (2021-2026) & (K Units) Table 27. Global Cas9 Nuclease Revenue by Type (2027-2032) & (K Units) Table 28. Global Cas9 Nuclease Revenue Market Share by Type (2021-2026) Table 29. Global Cas9 Nuclease Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Bioagriculture Table 31. Major Manufacturers of Gene Therapy Table 32. Major Manufacturers of Gene Editing Cell Line Construction Table 33. Major Manufacturers of Animal Models Table 34. Major Manufacturers of Other Table 35. Global Cas9 Nuclease Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Cas9 Nuclease Sales by Application (2021-2026) & (K Units) Table 37. Global Cas9 Nuclease Sales by Application (2027-2032) & (K Units) Table 38. Global Cas9 Nuclease Sales Market Share by Application (2021-2026) Table 39. Global Cas9 Nuclease Sales Market Share by Application (2027-2032) Table 40. Global Cas9 Nuclease Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Cas9 Nuclease Revenue by Application (2021-2026) & (K Units) Table 42. Global Cas9 Nuclease Revenue by Application (2027-2032) & (K Units) Table 43. Global Cas9 Nuclease Revenue Market Share by Application (2021-2026) Table 44. Global Cas9 Nuclease Revenue Market Share by Application (2027-2032) Table 45. Global Cas9 Nuclease Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Cas9 Nuclease Sales by Region (2021-2026) & (K Units) Table 47. Global Cas9 Nuclease Sales Market Share by Region (2021-2026) Table 48. Global Cas9 Nuclease Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Cas9 Nuclease Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 52. North America Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 53. Europe Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 55. Europe Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Cas9 Nuclease Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Cas9 Nuclease Sales by Country (2027-2032) & (K Units) Table 62. Global Cas9 Nuclease Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Cas9 Nuclease Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Cas9 Nuclease Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Cas9 Nuclease Revenue Market Share by Region (2021-2026) Table 66. Global Cas9 Nuclease Revenue Market Share by Region (2027-2032) Table 67. SBS Genetech Company Information Table 68. SBS Genetech Business Overview Table 69. SBS Genetech Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. SBS Genetech Cas9 Nuclease Product Portfolio Table 71. SBS Genetech Recent Development Table 72. Novoprotein Company Information Table 73. Novoprotein Business Overview Table 74. Novoprotein Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novoprotein Cas9 Nuclease Product Portfolio Table 76. Novoprotein Recent Development Table 77. Agilent Company Information Table 78. Agilent Business Overview Table 79. Agilent Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Agilent Cas9 Nuclease Product Portfolio Table 81. Agilent Recent Development Table 82. Thermo Fisher Scientific Company Information Table 83. Thermo Fisher Scientific Business Overview Table 84. Thermo Fisher Scientific Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Thermo Fisher Scientific Cas9 Nuclease Product Portfolio Table 86. Thermo Fisher Scientific Recent Development Table 87. Stemcell Technologies Company Information Table 88. Stemcell Technologies Business Overview Table 89. Stemcell Technologies Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Stemcell Technologies Cas9 Nuclease Product Portfolio Table 91. Stemcell Technologies Recent Development Table 92. Sigma-Aldrich Company Information Table 93. Sigma-Aldrich Business Overview Table 94. Sigma-Aldrich Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sigma-Aldrich Cas9 Nuclease Product Portfolio Table 96. Sigma-Aldrich Recent Development Table 97. OriGene Technologies Company Information Table 98. OriGene Technologies Business Overview Table 99. OriGene Technologies Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. OriGene Technologies Cas9 Nuclease Product Portfolio Table 101. OriGene Technologies Recent Development Table 102. Nippon Gene Company Information Table 103. Nippon Gene Business Overview Table 104. Nippon Gene Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Nippon Gene Cas9 Nuclease Product Portfolio Table 106. Nippon Gene Recent Development Table 107. New England Biolabs Company Information Table 108. New England Biolabs Business Overview Table 109. New England Biolabs Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. New England Biolabs Cas9 Nuclease Product Portfolio Table 111. New England Biolabs Recent Development Table 112. Kactus Company Information Table 113. Kactus Business Overview Table 114. Kactus Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Kactus Cas9 Nuclease Product Portfolio Table 116. Kactus Recent Development Table 117. Horizo​​n Discovery Company Information Table 118. Horizo​​n Discovery Business Overview Table 119. Horizo​​n Discovery Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Horizo​​n Discovery Cas9 Nuclease Product Portfolio Table 121. Horizo​​n Discovery Recent Development Table 122. GenScript Company Information Table 123. GenScript Business Overview Table 124. GenScript Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. GenScript Cas9 Nuclease Product Portfolio Table 126. GenScript Recent Development Table 127. Danaher Company Information Table 128. Danaher Business Overview Table 129. Danaher Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Danaher Cas9 Nuclease Product Portfolio Table 131. Danaher Recent Development Table 132. BPS Bioscience Company Information Table 133. BPS Bioscience Business Overview Table 134. BPS Bioscience Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. BPS Bioscience Cas9 Nuclease Product Portfolio Table 136. BPS Bioscience Recent Development Table 137. Applied Biological Materials Company Information Table 138. Applied Biological Materials Business Overview Table 139. Applied Biological Materials Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Applied Biological Materials Cas9 Nuclease Product Portfolio Table 141. Applied Biological Materials Recent Development Table 142. Abnova Company Information Table 143. Abnova Business Overview Table 144. Abnova Cas9 Nuclease Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Abnova Cas9 Nuclease Product Portfolio Table 146. Abnova Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Cas9 Nuclease Distributors List Table 150. Cas9 Nuclease Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Cas9 Nuclease Product Image Figure 2. Global Cas9 Nuclease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cas9 Nuclease Market Size (2021-2032) & (US$ Million) Figure 4. Global Cas9 Nuclease Sales (2021-2032) & (K Units) Figure 5. Global Cas9 Nuclease Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cas9 Nuclease Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cas9 mRNA Image Figure 9. Cas9 Protein Image Figure 10. Cas9 Lentivirus Image Figure 11. Cas9 Plasmid Image Figure 12. Global Cas9 Nuclease Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Cas9 Nuclease Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cas9 Nuclease Sales Market Share by Type (2021-2032) Figure 15. Global Cas9 Nuclease Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Cas9 Nuclease Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cas9 Nuclease Revenue Market Share by Type (2021-2032) Figure 18. Bioagriculture Image Figure 19. Gene Therapy Image Figure 20. Gene Editing Cell Line Construction Image Figure 21. Animal Models Image Figure 22. Other Image Figure 23. Global Cas9 Nuclease Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Cas9 Nuclease Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cas9 Nuclease Sales Market Share by Application (2021-2032) Figure 26. Global Cas9 Nuclease Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Cas9 Nuclease Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Cas9 Nuclease Revenue Market Share by Application (2021-2032) Figure 29. North America Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 31. U.S. Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 36. Germany Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 43. China Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Cas9 Nuclease Sales Market Share by Country (2021-2032) Figure 51. Brazil Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Cas9 Nuclease Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Cas9 Nuclease Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Cas9 Nuclease Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Cas9 Nuclease Revenue (2021-2032) & (US$ Million) Figure 62. North America Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Cas9 Nuclease Revenue (2021-2032) & (US$ Million) Figure 64. Europe Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Cas9 Nuclease Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Cas9 Nuclease Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cas9 Nuclease Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Cas9 Nuclease Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Cas9 mRNA
  • Cas9 Protein
  • Cas9 Lentivirus
  • Cas9 Plasmid
Applications
  • Bioagriculture
  • Gene Therapy
  • Gene Editing Cell Line Construction
  • Animal Models
  • Other
Companies covered
  • SBS Genetech
  • Novoprotein
  • Agilent
  • Thermo Fisher Scientific
  • Stemcell Technologies
  • Sigma-Aldrich
  • OriGene Technologies
  • Nippon Gene
  • New England Biolabs
  • Kactus
  • Horizo​​n Discovery
  • GenScript
  • Danaher
  • BPS Bioscience
  • Applied Biological Materials
  • Abnova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cas9 Nuclease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cas9 Nuclease Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cas9 Nuclease Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cas9 Nuclease Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cas9 Nuclease Market Dynamics
  1. 2.1 Cas9 Nuclease Industry Trends
  2. 2.2 Cas9 Nuclease Industry Drivers
  3. 2.3 Cas9 Nuclease Industry Opportunities and Challenges
  4. 2.4 Cas9 Nuclease Industry Restraints
3 Cas9 Nuclease Market by Manufacturers
  1. 3.1 Global Cas9 Nuclease Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cas9 Nuclease Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cas9 Nuclease Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cas9 Nuclease Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cas9 Nuclease Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cas9 Nuclease Manufacturers, Product Type & Application
  7. 3.7 Global Cas9 Nuclease Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cas9 Nuclease Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cas9 Nuclease Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cas9 Nuclease Tier 1, Tier 2, and Tier 3
4 Cas9 Nuclease Market by Type
  1. 4.1 Cas9 Nuclease Type Introduction
  2. 4.1.1 Cas9 mRNA
  3. 4.1.2 Cas9 Protein
  4. 4.1.3 Cas9 Lentivirus
  5. 4.1.4 Cas9 Plasmid
  6. 4.2 Global Cas9 Nuclease Sales by Type
  7. 4.2.1 Global Cas9 Nuclease Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cas9 Nuclease Sales by Type (2021-2032)
  9. 4.2.3 Global Cas9 Nuclease Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cas9 Nuclease Revenue by Type
  11. 4.3.1 Global Cas9 Nuclease Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cas9 Nuclease Revenue by Type (2021-2032)
  13. 4.3.3 Global Cas9 Nuclease Revenue Market Share by Type (2021-2032)
5 Cas9 Nuclease Market by Application
  1. 5.1 Cas9 Nuclease Application Introduction
  2. 5.1.1 Bioagriculture
  3. 5.1.2 Gene Therapy
  4. 5.1.3 Gene Editing Cell Line Construction
  5. 5.1.4 Animal Models
  6. 5.1.5 Other
  7. 5.2 Global Cas9 Nuclease Sales by Application
  8. 5.2.1 Global Cas9 Nuclease Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cas9 Nuclease Sales by Application (2021-2032)
  10. 5.2.3 Global Cas9 Nuclease Sales Market Share by Application (2021-2032)
  11. 5.3 Global Cas9 Nuclease Revenue by Application
  12. 5.3.1 Global Cas9 Nuclease Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cas9 Nuclease Revenue by Application (2021-2032)
  14. 5.3.3 Global Cas9 Nuclease Revenue Market Share by Application (2021-2032)
6 Global Cas9 Nuclease Sales by Region
  1. 6.1 Global Cas9 Nuclease Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cas9 Nuclease Sales by Region (2021-2032)
  3. 6.2.1 Global Cas9 Nuclease Sales by Region (2021-2026)
  4. 6.2.2 Global Cas9 Nuclease Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cas9 Nuclease Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cas9 Nuclease Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cas9 Nuclease Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cas9 Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cas9 Nuclease Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cas9 Nuclease Revenue by Region
  1. 7.1 Global Cas9 Nuclease Revenue by Region
  2. 7.1.1 Global Cas9 Nuclease Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cas9 Nuclease Revenue by Region (2021-2026)
  4. 7.1.3 Global Cas9 Nuclease Revenue by Region (2027-2032)
  5. 7.1.4 Global Cas9 Nuclease Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cas9 Nuclease Revenue (2021-2032)
  8. 7.2.2 North America Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cas9 Nuclease Revenue (2021-2032)
  11. 7.3.2 Europe Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cas9 Nuclease Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cas9 Nuclease Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cas9 Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SBS Genetech
  2. 8.1.1 SBS Genetech Company Information
  3. 8.1.2 SBS Genetech Business Overview
  4. 8.1.3 SBS Genetech Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SBS Genetech Cas9 Nuclease Product Portfolio
  6. 8.1.5 SBS Genetech Recent Developments
  7. 8.2 Novoprotein
  8. 8.2.1 Novoprotein Company Information
  9. 8.2.2 Novoprotein Business Overview
  10. 8.2.3 Novoprotein Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novoprotein Cas9 Nuclease Product Portfolio
  12. 8.2.5 Novoprotein Recent Developments
  13. 8.3 Agilent
  14. 8.3.1 Agilent Company Information
  15. 8.3.2 Agilent Business Overview
  16. 8.3.3 Agilent Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Cas9 Nuclease Product Portfolio
  18. 8.3.5 Agilent Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Cas9 Nuclease Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 Stemcell Technologies
  26. 8.5.1 Stemcell Technologies Company Information
  27. 8.5.2 Stemcell Technologies Business Overview
  28. 8.5.3 Stemcell Technologies Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stemcell Technologies Cas9 Nuclease Product Portfolio
  30. 8.5.5 Stemcell Technologies Recent Developments
  31. 8.6 Sigma-Aldrich
  32. 8.6.1 Sigma-Aldrich Company Information
  33. 8.6.2 Sigma-Aldrich Business Overview
  34. 8.6.3 Sigma-Aldrich Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sigma-Aldrich Cas9 Nuclease Product Portfolio
  36. 8.6.5 Sigma-Aldrich Recent Developments
  37. 8.7 OriGene Technologies
  38. 8.7.1 OriGene Technologies Company Information
  39. 8.7.2 OriGene Technologies Business Overview
  40. 8.7.3 OriGene Technologies Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OriGene Technologies Cas9 Nuclease Product Portfolio
  42. 8.7.5 OriGene Technologies Recent Developments
  43. 8.8 Nippon Gene
  44. 8.8.1 Nippon Gene Company Information
  45. 8.8.2 Nippon Gene Business Overview
  46. 8.8.3 Nippon Gene Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Gene Cas9 Nuclease Product Portfolio
  48. 8.8.5 Nippon Gene Recent Developments
  49. 8.9 New England Biolabs
  50. 8.9.1 New England Biolabs Company Information
  51. 8.9.2 New England Biolabs Business Overview
  52. 8.9.3 New England Biolabs Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 New England Biolabs Cas9 Nuclease Product Portfolio
  54. 8.9.5 New England Biolabs Recent Developments
  55. 8.10 Kactus
  56. 8.10.1 Kactus Company Information
  57. 8.10.2 Kactus Business Overview
  58. 8.10.3 Kactus Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kactus Cas9 Nuclease Product Portfolio
  60. 8.10.5 Kactus Recent Developments
  61. 8.11 Horizo​​n Discovery
  62. 8.11.1 Horizo​​n Discovery Company Information
  63. 8.11.2 Horizo​​n Discovery Business Overview
  64. 8.11.3 Horizo​​n Discovery Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Horizo​​n Discovery Cas9 Nuclease Product Portfolio
  66. 8.11.5 Horizo​​n Discovery Recent Developments
  67. 8.12 GenScript
  68. 8.12.1 GenScript Company Information
  69. 8.12.2 GenScript Business Overview
  70. 8.12.3 GenScript Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GenScript Cas9 Nuclease Product Portfolio
  72. 8.12.5 GenScript Recent Developments
  73. 8.13 Danaher
  74. 8.13.1 Danaher Company Information
  75. 8.13.2 Danaher Business Overview
  76. 8.13.3 Danaher Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Danaher Cas9 Nuclease Product Portfolio
  78. 8.13.5 Danaher Recent Developments
  79. 8.14 BPS Bioscience
  80. 8.14.1 BPS Bioscience Company Information
  81. 8.14.2 BPS Bioscience Business Overview
  82. 8.14.3 BPS Bioscience Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BPS Bioscience Cas9 Nuclease Product Portfolio
  84. 8.14.5 BPS Bioscience Recent Developments
  85. 8.15 Applied Biological Materials
  86. 8.15.1 Applied Biological Materials Company Information
  87. 8.15.2 Applied Biological Materials Business Overview
  88. 8.15.3 Applied Biological Materials Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Applied Biological Materials Cas9 Nuclease Product Portfolio
  90. 8.15.5 Applied Biological Materials Recent Developments
  91. 8.16 Abnova
  92. 8.16.1 Abnova Company Information
  93. 8.16.2 Abnova Business Overview
  94. 8.16.3 Abnova Cas9 Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abnova Cas9 Nuclease Product Portfolio
  96. 8.16.5 Abnova Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cas9 Nuclease Value Chain Analysis
  2. 9.1.1 Cas9 Nuclease Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cas9 Nuclease Production Mode & Process
  6. 9.2 Cas9 Nuclease Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cas9 Nuclease Distributors
  9. 9.2.3 Cas9 Nuclease Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst